Opportunity
Simpler Grants.gov #HT942526AZRPTrRA
Army Solicits Transformative Alzheimer’s Research Proposals for FY26
Buyer
U.S. Army Medical Research Acquisition Activity
Posted
May 01, 2026
Respond By
September 24, 2026
Identifier
HT942526AZRPTrRA
NAICS
541715
The Dept. of the Army is inviting proposals for the FY26 Alzheimer’s Research Program Transforming Research Award, targeting transformative research in Alzheimer’s disease and related dementias. - Government Buyer: - Dept. of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - Products/Services Requested: - Research services focused on: - Advancing knowledge and validation of risk/protective factors for Alzheimer’s disease - Developing methods, technologies, and strategies to reduce risk and prevent AD/ADRD - Clinical research permitted (excluding clinical trials and animal research) - Preliminary data required for projects enrolling human subjects - Community collaboration required for human subject research - Career Initiation or Transition (CIT) Partnership Option available for collaborative teams - Unique/Notable Requirements: - Projects must address at least one of two focus areas: Risk Factor Knowledge or Risk Reduction Solutions - CIT Partnership Option allows collaborative partnerships, with each PI named on separate awards if funded - Up to four awards anticipated, with a total funding pool of $4,000,000 - Maximum period of performance is three years per award - No specific OEMs or commercial vendors are mentioned; the focus is on scientific research and development.
Description
The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD). Applications must address at least one of the following focus areas: Risk Factor Knowledge or Risk Reduction Solutions. Clinical research is allowed, but clinical trials and animal research are prohibited. Preliminary data and community collaboration for research enrolling human subjects are required. The award includes a Career Initiation or Transition (CIT) Partnership Option for collaborative partnerships.